Reducing complications from cesarean deliveries by preventing adhesions
Official title: Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
Funded at Luna Labs USA, LLC · NIH-10931679 · Data updated 2026-11-12
This study is testing a new sprayable gel called AeroVeil to see if it can help prevent painful scar tissue from forming after cesarean deliveries, especially for moms in minority communities, to make their recovery easier and healthier.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Luna Labs USA, LLC NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | September 18, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $857,868 |
| NIH project number | 5R44HD114305-02 |
| Project ID | NIH-10931679 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women who are planning to undergo a cesarean delivery, particularly those from minority communities who may face higher risks of complications.
✕Less likely to help
Patients who are not undergoing cesarean deliveries or those with no history of abdominal surgeries may not benefit from this research.
What this research studies
This research investigates a new technology aimed at preventing postoperative adhesions that can occur after cesarean deliveries. It focuses on a patented sprayable hydrogel called AeroVeil, which has shown promise in reducing adhesion formation in animal models. The study will transition this technology to gynecologic applications, assessing its safety and effectiveness in real-world scenarios. By addressing the complications associated with cesarean sections, particularly in minority communities, the research aims to improve maternal health outcomes.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of painful adhesions and improve recovery times for women undergoing cesarean deliveries.
How similar studies have gone: Previous studies have shown success with similar adhesion prevention technologies in animal models, but this specific application in gynecologic procedures is novel.
Where this research is happening
-
Luna Labs USA, LLC
Charlottesville, United States Active
Researchers
- Principal investigator: Costella, Lauren — Luna Labs USA, LLC
- Study coordinator: Costella, Lauren
Related research
Other NIH-funded projects on the same topics.
-
Ketamine to reduce postpartum depression and pain after cesarean delivery
This grant explores a ketamine approach to help new mothers after cesarean delivery feel better sooner and with less pain.
-
Preventing Mood and Anxiety Problems After Cesarean Delivery
A low-cost, one-hour intervention given to pregnant patients having a cesarean delivery to help reduce mood, anxiety, and trauma symptoms later on.
-
Calcium given during cesarean to reduce severe bleeding
A simple, patient-friendly trial will test whether giving calcium through an IV at cesarean delivery can lower the risk of heavy bleeding after birth for mothers.
-
Adding azithromycin before a planned cesarean to lower infection risk
Giving azithromycin along with the usual antibiotic to people having a scheduled C-section to lower the chance of infections after delivery.
-
Using ketamine to help mothers with depression and pain after cesarean delivery
This study is looking at how ketamine can help new moms feel better by reducing postpartum depression and pain after a cesarean delivery, and it aims to find the best dose to improve their mood and manage pain safely.
-
Investigating the long-term effects of azithromycin on childhood obesity and neurodevelopment after cesarean delivery
This study is looking at how giving the antibiotic azithromycin to mothers during childbirth affects their children's growth and brain development, especially for those born by cesarean section, and it compares these kids to others who didn't get the antibiotic to see if there are any long-term effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.